The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Anti-Malarial Drug-Global Market Insights and Sales Trends 2024

Anti-Malarial Drug-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1858764

No of Pages : 103

Ask Your Query
Synopsis
The global Anti-Malarial Drug market size is expected to reach US$ 818.1 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Malarial Drug in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy, E-Commerce and Others, are propelling Anti-Malarial Drug market. Plasmodium Falciparum, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasmodium Vivax segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Malarial Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Malarial Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Malarial Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Malarial Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Malarial Drug covered in this report include GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, Bayer, Ipca, Merck, F. Hoffmann-La Roche and Novartis, etc.
The global Anti-Malarial Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Global Anti-Malarial Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Malarial Drug market, Segment by Type:
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Global Anti-Malarial Drug market, by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-Malarial Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-Malarial Drug Market Overview
1.1 Anti-Malarial Drug Product Overview
1.2 Anti-Malarial Drug Market Segment by Type
1.2.1 Plasmodium Falciparum
1.2.2 Plasmodium Vivax
1.2.3 Plasmodium Malariae
1.2.4 Plasmodium Ovale
1.3 Global Anti-Malarial Drug Market Size by Type
1.3.1 Global Anti-Malarial Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-Malarial Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-Malarial Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Malarial Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-Malarial Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-Malarial Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-Malarial Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-Malarial Drug Sales Breakdown by Type (2018-2023)
2 Global Anti-Malarial Drug Market Competition by Company
2.1 Global Top Players by Anti-Malarial Drug Sales (2018-2023)
2.2 Global Top Players by Anti-Malarial Drug Revenue (2018-2023)
2.3 Global Top Players by Anti-Malarial Drug Price (2018-2023)
2.4 Global Top Manufacturers Anti-Malarial Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Malarial Drug Market Competitive Situation and Trends
2.5.1 Anti-Malarial Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Malarial Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Malarial Drug Market
2.8 Key Manufacturers Anti-Malarial Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Malarial Drug Status and Outlook by Region
3.1 Global Anti-Malarial Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Malarial Drug Historic Market Size by Region
3.2.1 Global Anti-Malarial Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-Malarial Drug Sales in Value by Region (2018-2023)
3.2.3 Global Anti-Malarial Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-Malarial Drug Forecasted Market Size by Region
3.3.1 Global Anti-Malarial Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Malarial Drug Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Malarial Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Malarial Drug by Application
4.1 Anti-Malarial Drug Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 E-Commerce
4.1.4 Others
4.2 Global Anti-Malarial Drug Market Size by Application
4.2.1 Global Anti-Malarial Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-Malarial Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-Malarial Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Malarial Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-Malarial Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-Malarial Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-Malarial Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-Malarial Drug Sales Breakdown by Application (2018-2023)
5 North America Anti-Malarial Drug by Country
5.1 North America Anti-Malarial Drug Historic Market Size by Country
5.1.1 North America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Malarial Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-Malarial Drug Sales in Value by Country (2018-2023)
5.2 North America Anti-Malarial Drug Forecasted Market Size by Country
5.2.1 North America Anti-Malarial Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Malarial Drug Sales in Value by Country (2024-2029)
6 Europe Anti-Malarial Drug by Country
6.1 Europe Anti-Malarial Drug Historic Market Size by Country
6.1.1 Europe Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Malarial Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-Malarial Drug Sales in Value by Country (2018-2023)
6.2 Europe Anti-Malarial Drug Forecasted Market Size by Country
6.2.1 Europe Anti-Malarial Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Malarial Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Malarial Drug by Region
7.1 Asia-Pacific Anti-Malarial Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Malarial Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Malarial Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-Malarial Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-Malarial Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Malarial Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Malarial Drug Sales in Value by Region (2024-2029)
8 Latin America Anti-Malarial Drug by Country
8.1 Latin America Anti-Malarial Drug Historic Market Size by Country
8.1.1 Latin America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Malarial Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-Malarial Drug Sales in Value by Country (2018-2023)
8.2 Latin America Anti-Malarial Drug Forecasted Market Size by Country
8.2.1 Latin America Anti-Malarial Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Malarial Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Malarial Drug by Country
9.1 Middle East and Africa Anti-Malarial Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Malarial Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-Malarial Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-Malarial Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Malarial Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Malarial Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Anti-Malarial Drug Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Ranbaxy
10.2.1 Ranbaxy Company Information
10.2.2 Ranbaxy Introduction and Business Overview
10.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ranbaxy Anti-Malarial Drug Products Offered
10.2.5 Ranbaxy Recent Development
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Information
10.3.2 Zydus Cadila Introduction and Business Overview
10.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zydus Cadila Anti-Malarial Drug Products Offered
10.3.5 Zydus Cadila Recent Development
10.4 Alvizia
10.4.1 Alvizia Company Information
10.4.2 Alvizia Introduction and Business Overview
10.4.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Alvizia Anti-Malarial Drug Products Offered
10.4.5 Alvizia Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Anti-Malarial Drug Products Offered
10.5.5 Bayer Recent Development
10.6 Ipca
10.6.1 Ipca Company Information
10.6.2 Ipca Introduction and Business Overview
10.6.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ipca Anti-Malarial Drug Products Offered
10.6.5 Ipca Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Anti-Malarial Drug Products Offered
10.7.5 Merck Recent Development
10.8 F. Hoffmann-La Roche
10.8.1 F. Hoffmann-La Roche Company Information
10.8.2 F. Hoffmann-La Roche Introduction and Business Overview
10.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Products Offered
10.8.5 F. Hoffmann-La Roche Recent Development
10.9 Novartis
10.9.1 Novartis Company Information
10.9.2 Novartis Introduction and Business Overview
10.9.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis Anti-Malarial Drug Products Offered
10.9.5 Novartis Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Information
10.10.2 Pfizer Introduction and Business Overview
10.10.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Pfizer Anti-Malarial Drug Products Offered
10.10.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Malarial Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Malarial Drug Industrial Chain Analysis
11.4 Anti-Malarial Drug Market Dynamics
11.4.1 Anti-Malarial Drug Industry Trends
11.4.2 Anti-Malarial Drug Market Drivers
11.4.3 Anti-Malarial Drug Market Challenges
11.4.4 Anti-Malarial Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Malarial Drug Distributors
12.3 Anti-Malarial Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock